ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 2 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,591 | -39.8% | 179,700 | -32.4% | 0.01% | -27.3% |
| Q2 2023 | $7,620 | -99.2% | 265,700 | +895.6% | 0.01% | +1000.0% |
| Q4 2021 | $988,000 | -1.0% | 26,687 | -9.5% | 0.00% | 0.0% |
| Q2 2021 | $998,000 | -83.1% | 29,500 | -79.3% | 0.00% | -85.7% |
| Q1 2021 | $5,898,000 | +2231.2% | 142,800 | +512.9% | 0.01% | – |
| Q4 2019 | $253,000 | -24.3% | 23,300 | -28.3% | 0.00% | – |
| Q3 2019 | $334,000 | – | 32,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 8,394 | $264,663 | 0.19% |
| Global Wealth Strategies & Associates | 100 | $3,153 | 0.00% |